HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.

about

A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study

P2860

Q28647934-5CC8A791-FE8C-4DDB-B171-945D4DAF7C76

P2860

HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.

Item

http://www.wikidata.org/entity/Q39145828

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@en

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@nl

type

Item

label

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@en

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@nl

prefLabel

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@en

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@nl

P1476

HLA-A2-restricted cytotoxic T ...... prostate cancer immunotherapy.

@en

P2093

B Zhu

http://www.w3.org/2001/XMLSchema#string

G Li

http://www.w3.org/2001/XMLSchema#string

J Guo

http://www.w3.org/2001/XMLSchema#string

J Tang

http://www.w3.org/2001/XMLSchema#string

Q-Y Zhou

http://www.w3.org/2001/XMLSchema#string

X-B Cao

http://www.w3.org/2001/XMLSchema#string

X-H Pan

http://www.w3.org/2001/XMLSchema#string

Z-J Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Pro-urokinase-type plasminogen activator is a substrate for hepsin

Dendritic cells and the control of immunity

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Proteolytic activation of pro-macrophage-stimulating protein by hepsin.

Delineation of prognostic biomarkers in prostate cancer

Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation.

Mechanisms of MHC class I--restricted antigen processing.

Estimates of the cancer incidence and mortality in Europe in 2006.

Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells.

Target molecules in specific immunotherapy against prostate cancer.

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/SJI.12083

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23721092

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.

about

P2860

P2860

HLA-A2-restricted cytotoxic T lymphocyte epitopes from human hepsin as novel targets for prostate cancer immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921